Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.

Massimo Montalto, Marcello Covino, Giovanni Cammarota, Antonio Gasbarrini, Giovanni Battista Gasbarrini, Valentina Curigliano, Luca Santoro, Sara Dalvai, Fabio D'Onofrio, M Lombardi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

16 Citazioni (Scopus)

Abstract

OBJECTIVE: Non-steroidal anti-inflammatory drugs (NSAID) can induce enteropathy. Aspirin ingestion is associated with a lower small-intestinal inflammation than other NSAID. Faecal calprotectin concentrations have recently been proposed as a simple non-invasive test to identify NSAID enteropathy. The aim of our pilot study was to evaluate calprotectin concentrations in patients on treatment with low-dose aspirin. METHODS: Twenty-two patients on prophylactic treatment with aspirin were recruited. Twenty-five healthy volunteers were enrolled as a control group. Faecal calprotectin concentrations were determined by enzyme-linked immunosorbent assay. Statistical analysis was performed by t-test for unpaired data. RESULTS: The mean faecal calprotectin concentration in patients (57.95+/-44.28 microg/g) did not show significant differences compared with controls (45.76+/-26.45 microg/g; P=0.251). CONCLUSIONS: We found that low-dose aspirin does not induce an increase in faecal calprotectin increase
Lingua originaleEnglish
pagine (da-a)965-967
Numero di pagine3
RivistaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Stato di pubblicazionePubblicato - 2006

Keywords

  • prophylactic

Fingerprint Entra nei temi di ricerca di 'Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.'. Insieme formano una fingerprint unica.

Cita questo